Identifying and Tracking Low-Frequency Virus-Specific TCR Clonotypes Using High-Throughput Sequencing

Kyle J. Wolf(Saint Louis University), Richard J. DiPaolo(UCLouvain Saint-Louis Brussels), Pavlo Gilchuk(AstraZeneca (Japan)), Sebastian Joyce(Walther Cancer Foundation), Courtney Schiebout(Saint Louis University), R. Mark L. Buller(National Institute of Allergy and Infectious Diseases), Tae-Hyuk Ahn(Saint Louis University), Tyler Hether(Nanostring Technologies (United States)), Amrendra Kumar(University of Delhi), Ahmad Rajeh(Massachusetts General Hospital), Julie Maybruck(Federal Bureau of Investigation)
Cell Reports
November 1, 2018
10.1016/j.celrep.2018.11.009
Cited by 30

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
|Cell|2021|409